AGIOS PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $260.5M | $619.1M | $160.8M |
| FY2017 | $238.9M | $614.4M | $102.7M |
| FY2018 | $170.9M | $858.5M | $70.5M |
| FY2019 | $250.2M | $890.7M | $80.9M |
| FY2020 | $453.5M | $853.0M | $127.4M |
| FY2021 | $145.8M | $1.44B | $203.1M |
| FY2022 | $137.9M | $1.24B | $139.3M |
| FY2023 | $126.1M | $937.1M | $88.2M |
| FY2024 | $122.2M | $1.66B | $76.2M |
| FY2025 | $104.1M | $1.30B | $89.1M |